Inhaler article holder

A swirling airflow-inducing holder for inhaler articles simplifies the inhaler system, enabling efficient nicotine delivery at smoking-like inhalation volumes and airflow rates, addressing the limitations of traditional dry powder inhalers.

JP7586905B2Active Publication Date: 2024-11-19PHILIP MORRIS PRODUCTS SA

Patent Information

Application Number
JP2022521017
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-10-25
Filing Date
2020-10-23
Publication Date
2024-11-19
Estimated Expiration
2040-10-23

AI Technical Summary

Technical Problem

Dry powder inhalers are not suitable for delivering dry powder particles at inhalation volumes and airflow rates comparable to conventional smoking methods, often requiring complex operations and moving parts.

Method used

A holder for an inhaler article that induces swirling inhalation airflow, simplifying the inhaler system by separating the holder from the inhaler article, allowing for a reusable holder that activates the inhaler and delivers nicotine particles at inhalation volumes similar to traditional smoking methods.

Benefits of technology

The solution reduces inhaler complexity, lowers manufacturing costs, and efficiently delivers nicotine particles to the lungs at appropriate airflow rates, mimicking conventional smoking with a simpler inhaler design.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007586905000001
    Figure 0007586905000001
  • Figure 0007586905000002
    Figure 0007586905000002
  • Figure 0007586905000003
    Figure 0007586905000003
Patent Text Reader

Abstract

The inhaler article holder includes a housing with a housing cavity for receiving an inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve includes the sleeve cavity and is movable within the housing cavity along the longitudinal axis of the housing. The sleeve includes a first open end and a second opposite end. The first open end is configured to receive the inhaler article, and the second opposite end of the sleeve is configured to allow air to enter the sleeve cavity. The second opposite end of the sleeve is configured to induce swirl in the air entering the sleeve cavity.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to a holder for an inhaler article and an inhaler system including the holder and the inhaler article, The holder is configured to generate a swirling inhalation airflow and deliver the swirling airflow to the inhaler article during consumption. [Background technology]

[0002] Dry powder inhalers are not always fully adequate to deliver dry powder particles to the lungs at inhalation volumes or airflow rates that are within the range of traditional smoking methods. Dry powder inhalers can be complicated to operate or involve moving parts. Dry powder inhalers often attempt to deliver the entire dry powder dose or capsule load in a single breath.

[0003] It would be desirable to provide an inhaler system that minimizes complex parts, particularly with respect to the inhaler article of the inhaler system. It would be desirable to provide an inhaler system that efficiently depletes a capsule of particles during consumption. It would be desirable to provide a holder for an inhaler article that induces a swirling inhalation airflow within the inhaler article. Summary of the Invention [Problem to be solved by the invention]

[0004] It would be desirable to provide a holder for an inhaler article that activates the inhaler article and holds the inhaler article during consumption. It would be desirable to provide an inhaler system that includes a low profile, reusable holder for an inhaler article that can activate the inhaler article. It would be desirable to provide a nicotine powder inhaler that provides nicotine particles to the lungs at an inhalation volume or airflow that is within the inhalation volume or airflow of traditional smoking methods. It would also be desirable to deliver nicotine powder using an inhaler article that has a configuration similar to a traditional cigarette. [Means for solving the problem]

[0005] The present disclosure is directed to a holder for an inhaler article. The holder is configured to induce a swirling inhalation airflow into the inhaler article during consumption. The holder and the inhaler article may form an inhaler system, and the present disclosure is also directed to this system.

[0006] According to an aspect of the invention, a holder for an inhaler article includes a housing having a housing cavity for receiving an inhaler article, and a sleeve configured to hold an inhaler article within the housing cavity. The sleeve has a sleeve cavity and is movable within the housing cavity along a longitudinal axis of the housing. The sleeve has a first open end and a second opposing end. The second opposing end of the sleeve is configured to allow air to enter the sleeve cavity. The second opposing end of the sleeve is configured to induce a swirl in the air entering the sleeve cavity.

[0007] According to an aspect of the invention, a holder for an inhaler article includes a housing with a housing cavity for receiving an inhaler article and a sleeve configured to hold an inhaler article within the housing cavity. The sleeve includes a sleeve cavity and is movable within the housing cavity along a longitudinal axis of the housing. The sleeve includes a first open end and a second opposite end. The first open end is configured to receive an inhaler article and the second opposite end of the sleeve includes a tubular element having a central passage in fluid communication with the sleeve cavity and at least one air inlet. The at least one air inlet extends in a direction tangential to the central passage to allow air to enter the sleeve cavity and to induce a swirling airflow pattern in the air entering the sleeve cavity.

[0008] Advantageously, incorporating a swirl-generating structure into a reusable holder may simplify the structure of the inhaler article and reduce the complexity of the inhaler system. Inhaler articles that receive a swirling inhalation airflow may be easier to manufacture and may have a simpler structure than inhaler articles that must include a structure to induce or create a swirling inhalation airflow. Simpler inhaler articles may also present a smaller environmental burden.

[0009] The second opposite end of the sleeve may comprise a tubular element having a central passage in fluid communication with the sleeve cavity. The second opposite end may include at least one air inlet that allows air to enter into the central passage. The air entering the central passage may be air outside the sleeve. The at least one air inlet may extend in a direction tangential to the central passage. The tubular element may comprise at least two air inlets that extend tangential to the central passage. The tubular element may comprise at least three air inlets that extend tangential to the central passage. The at least one air inlet preferably extends in a transverse direction of the sleeve. The transverse direction of the sleeve is a direction perpendicular or perpendicular to a longitudinal direction defined by the sleeve. The sleeve is preferably cylindrical. These tangential air inlets cooperate with the intake airflow to create or induce a swirling or swirling airflow pattern in the central passage of the tubular member. When the inhaler article is received within the sleeve and tubular element of the holder, this swirling or swirled airflow pattern is directed throughout the inhaler article and out the mouthpiece of the inhaler article.

[0010] Advantageously, the tangential inhalation airflow into the tubular element induces a swirling or swirl airflow in the central passageway, which may be provided or directed into a capsule cavity of an inhaler article received in the sleeve of the holder, the swirling or swirl airflow inducing a capsule contained within the capsule cavity to rotate and release particles into the swirling or swirl airflow to the consumer.

[0011] The tubular element defining the central passage may extend into the sleeve cavity and may form an annular recess with the sleeve cavity configured to receive the distal end of the inhaler article. The tubular element defining the central passage may extend into the sleeve cavity and may form an annular recess with the sleeve cavity configured to hold the distal end of the inhaler article. The tubular element defining the central passage may be configured to extend into the distal end of the inhaler article received within the sleeve cavity. Substantially all of the inhaled air enters the tubular element in a direction that is tangential to the central passage.

[0012] Advantageously, providing features on the second, opposite end of the sleeve that mate with the received inhaler article may improve a secure airflow connection from the swirl-inducing sleeve to the inhaler article received within the sleeve, and the interference fit may provide a secure engagement of the inhaler article received within the sleeve such that the inhaler article does not become dislodged from the sleeve or an associated holder.

[0013] The holder may further include a piercing element secured to and extending from the inner surface of the housing, the piercing element configured to extend through the second opposite end of the sleeve and into the sleeve cavity along the longitudinal axis of the housing.

[0014] The holder may further include a spring element configured to bias the sleeve away from the piercing element. The sleeve may include an elongated slot extending along a longitudinal length of the sleeve. The housing may further include a pin extending from an inner surface of the housing cavity. The pin may be configured to mate with the elongated slot.

[0015] The sleeve may define a first air inlet zone having at least one air opening therethrough. The first air inlet zone is proximate a first open end of the sleeve. The first air inlet zone may be configured to allow air to flow into an airflow channel formed between the sleeve and the housing. The sleeve includes a second air inlet zone downstream from the first air inlet zone. The second air inlet zone includes a second opposite end of the sleeve configured to allow air to enter the sleeve cavity.

[0016] According to another aspect of the invention, an inhaler system comprises a holder for an inhaler article as described herein, and an inhaler article. A sleeve of the holder holds the inhaler article received within a sleeve cavity. The inhaler article comprises a body extending along a longitudinal axis of the inhaler from a mouthpiece end to a distal end. A capsule is disposed within the inhaler article body.

[0017] Advantageously, reusable holders that induce rotational or swirling airflow reduce the complexity of the associated consumable inhaler articles, which may reduce the overall manufacturing costs of these inhaler systems and improve the reliability or efficiency of capsule depletion.

[0018] A capsule is retained within the capsule cavity and configured to receive the swirling inlet airflow formed by the second opposite end of the sleeve, The capsule cavity is bounded downstream by a filter element and upstream by an open tubular element.

[0019] The open tubular element of the inhaler article mates with a second, opposite end of the sleeve tubular element. The mouthpiece end of the inhaler article may form the mouthpiece of the inhaler system.

[0020] Advantageously, an inhaler system in which the inhaler article has an open distal end that receives and delivers rotating or swirling airflow from the holder to the capsule cavity to induce rotation of the capsule within the inhaler article may reduce the overall manufacturing costs of the inhaler system and may improve reliable depletion of the capsule during consumption. Replaceable consumable inhaler articles provide a clean mouthpiece each time a consumed inhaler article is replaced with an unused inhaler article.

[0021] Advantageously, the inhaler system provides an inhaler system that minimizes moving parts. Advantageously, the inhaler system utilizes a separate holder that induces a rotating or swirling airflow in the inhaler article received in the holder. This may allow the holder to be reusable and the inhaler article to be disposable after a single use. Advantageously, the inhaler system efficiently delivers nicotine particles to the lungs at an inhalation volume or airflow within the inhalation volume or airflow of a traditional smoking method. The inhaler delivers nicotine powder using an inhaler article having a form similar to a traditional cigarette. The inhaler system described herein may deliver dry powder to the lungs at an inhalation volume or airflow within the inhalation volume or airflow of a traditional smoking method. The consumer may take multiple inhalations or "puffs", with each "puff" delivering a portion of the dry powder contained in the capsule contained within the capsule cavity. The inhaler article may have a form similar to a traditional cigarette and may mimic traditional smoking. The inhaler article may be simple to manufacture and convenient for the consumer to use.

[0022] Airflow management through the capsule cavity of the inhaler article may cause the capsule contained therein to rotate during inhalation and consumption. The capsule may contain particles containing nicotine (also referred to as "nicotine powder" or "nicotine particles"), and optionally, flavor-containing particles (also referred to as "flavor particles"). Rotation of the pierced capsule may suspend and aerosolize the nicotine particles released from the pierced capsule into the inhaled air moving through the inhaler article. The flavor particles may be larger than the nicotine particles and may assist in the delivery of the nicotine particles to the user's lungs, while the flavor particles preferentially reside in the user's mouth or oral cavity. The nicotine particles and optional flavor particles may be delivered using the inhaler article at an inhalation volume or airflow within the inhalation volume or airflow of a conventional smoking method.

[0023] The term "nicotine" refers to nicotine and nicotine derivatives, such as free base nicotine, nicotine salts, and the like.

[0024] The term "flavorant" or "flavor" refers to an organoleptic compound, composition, or material that alters, and is intended to alter, the taste or aroma characteristics of nicotine during its consumption or inhalation.

[0025] The terms "upstream" and "downstream" refer to the relative positions of the holder, the inhaler article, and the elements of the inhaler system described with respect to the direction of the inhalation airflow as it is drawn through the body of the holder, the inhaler article, and the inhaler system.

[0026] The terms "proximal" and "distal" are used to describe the relative positions of components or parts of components of a holder, an inhaler article, or a system. According to the present invention, the holder or an element forming the holder (such as a sleeve) has a proximal end that receives the inhaler article in use and an opposite distal end which may be a closed end or has an end closer to the proximal end of the holder. According to the present invention, the inhaler article has a proximal end. In use, nicotine particles exit the proximal end of the inhaler article for delivery to the user. The inhaler article has a distal end opposite the proximal end. The proximal end of the inhaler article may also be referred to as the mouth end.

[0027] The holder for an inhaler article described herein may be combined with an inhaler article that contains a capsule for activating the inhaler article by penetrating the capsule, and provides reliable activation of the capsule in the inhaler article (by piercing the capsule with a piercing element of the holder), and releases the particles contained within the capsule, allowing the article to deliver the particles to the consumer. Although the holder is separate from the inhaler article, the consumer may utilize both the inhaler article and the holder while consuming the particles released in the inhaler article. A plurality of these inhaler articles may be combined with a holder to form a system or kit. A single holder may be utilized with 10 or more, or 25 or more, or 50 or more, or 100 or more inhaler articles to activate (pierce or pierce) the capsule contained within each inhaler article, and provide reliable activation or, optionally, a visual indication (marking) of the activation of the inhaler article for each inhaler article.

[0028] The holder for an inhaler article includes a housing having a housing cavity for receiving an inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve has a sleeve cavity and is movable within the housing cavity along a longitudinal axis of the housing. The sleeve has a first open end and a second opposing end. The second opposing end of the sleeve is configured to allow air to enter the sleeve cavity. The second opposing end of the sleeve is configured to induce a swirl in the air entering the sleeve cavity.

[0029] The inhaler system comprises an inhaler article as described herein and a holder for the inhaler article. The sleeve of the holder holds the inhaler article received within the sleeve cavity. The inhaler article comprises a body extending along a longitudinal axis of the inhaler from a mouthpiece end to a distal end. A capsule is disposed within the inhaler article body.

[0030] The method includes inserting an inhaler article into a sleeve of a holder for an inhaler article as described herein. The inhaler article includes a body (the body extends along the inhaler longitudinal axis from the mouthpiece end to the distal end), a length of the body, and a capsule disposed within the inhaler article body. The inhaler article and sleeve are then moved toward the piercing element until the piercing element pierces the capsule. Air is then drawn into a second, opposite end of the sleeve of the holder, forming a swirling inhalation airflow. This swirling inhalation airflow is then directed into the inhaler article while the inhaler article is disposed within the holder for the inhaler article. The spent inhaler article may then be removed from the holder and disposed of. An unused inhaler article may then be inserted into the holder, and the method may be repeated.

[0031] The inhaler article is configured to receive the swirling inhalation airflow directly into the distal end of the inhaler article. The swirling inhalation airflow then continues downstream into the capsule cavity, inducing rotation of the capsule received in the capsule cavity. The activated capsule then releases a dose of particles downstream into the swirling inhalation airflow through a mouthpiece to a consumer. The distal or most upstream end of the inhaler article includes an open opening that defines an open central passage of the open tubular element. Thus, the swirling inhalation airflow is generated upstream from the inhaler article, and the swirling inhalation airflow enters the distal or most upstream end of the inhaler article.

[0032] The inhaler article comprises a body extending along the longitudinal axis of the inhaler from the mouthpiece end to the distal end. A capsule cavity is defined within the body bounded downstream by a filter element and upstream by an open tubular element defining a central passage. The central passage forms an open air inlet opening extending from the distal end of the body to the capsule cavity. A capsule is disposed within the capsule cavity, the central passage having a smaller diameter than the capsule. Thus, the capsule may not pass through the central passage and is retained within the capsule cavity.

[0033] The holder for an inhaler article includes a housing having a housing cavity for receiving an inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve has a sleeve cavity and is movable within the housing cavity along a longitudinal axis of the housing. The sleeve has a first open end and a second opposing end. The second opposing end of the sleeve is configured to allow air to enter the sleeve cavity. The second opposing end of the sleeve is configured to induce a swirl in the air entering the sleeve cavity.

[0034] A second, opposite end of the sleeve defines a swirl-generating element configured to generate a swirling or rotating inhalation airflow that may be delivered into the inhaler article to rotate the capsule and expel the dry powder contained within the capsule.

[0035] The second opposite end of the sleeve includes a tubular element having a central passage in fluid communication with the sleeve cavity. The second opposite end of the sleeve has at least one air inlet that allows air to enter the central passage. The at least one air inlet extends in a direction tangential to the central passage.

[0036] A second opposite end of the sleeve may have at least two air inlets that allow air to enter into the central passage, the at least two air inlets extending in a tangential direction relative to the central passage. A second opposite end of the sleeve may have at least two air inlets that allow air to enter into the central passage, the at least two air inlets extending in a tangential direction relative to the central passage.

[0037] A second opposite end of the sleeve may have at least three air inlets that allow air to enter into the central passageway, the at least three air inlets extending in a tangential direction relative to the central passageway. A second opposite end of the sleeve may have three air inlets that allow air to enter into the central passageway, the at least three air inlets extending in a tangential direction relative to the central passageway.

[0038] A second opposite end of the sleeve may have four air inlets that allow air to enter into the central passageway, the four air inlets extending in a direction tangential to the central passageway.

[0039] The tubular element may be coaxial with the longitudinal axis of the housing. The tubular element may be coaxial with the sleeve cavity. The tubular element may be coaxial with both the longitudinal axis of the housing and the sleeve cavity.

[0040] The tubular element having a central passage may have a diameter within the range of about 30% to about 70% of the diameter of the sleeve cavity.The tubular element having a central passage may have a diameter within the range of about 40% to about 60% of the diameter of the sleeve cavity.

[0041] A tubular element having a central passageway may extend into the sleeve cavity and may form an annular recess with the sleeve cavity configured to receive the distal end of the inhaler article. A tubular element having a central passageway may extend into the sleeve cavity and may form an annular recess with the sleeve cavity configured to hold the distal end of the inhaler article.

[0042] The tubular element having a central passageway may extend into a distal end of an inhaler article received within the sleeve cavity. The annular recess may be configured to retain the distal end of the inhaler article with an interference fit.

[0043] At least a portion of the tubular element having the central passage is located upstream from the inhaler article received in the sleeve. The tubular element having the central passage is preferably coaxial with the longitudinal axis of the received inhaler article.

[0044] The sleeve tubular element having a central passage may be sized to mate with the inhaler article distal end open tubular element defining the central passage. The sleeve tubular element having a central passage may abut the inhaler article distal end open tubular element defining the central passage. The sleeve tubular element having a central passage may interlock with the inhaler article distal end open tubular element defining the central passage. The sleeve tubular element having a central passage may be fitted within the inhaler article distal end tubular element defining the central passage. The sleeve tubular element central passage may have an inner diameter within the range of about 3 mm to about 5 mm, or about 4 mm.

[0045] The sleeve tubular element having a central passage may include at least one air inlet extending in a direction tangential to the central passage. The tubular element may include at least two air inlets extending in a direction tangential to the central passage. The tubular element may include at least three air inlets extending in a direction tangential to the central passage.

[0046] The one or more air inlets may extend through a sidewall forming an opposite second end of the sleeve. The one or more air inlets may extend perpendicular to a longitudinal axis of the sleeve or housing. The one or more air inlets may extend perpendicular to a longitudinal axis of a tubular element having a central passageway.

[0047] The sleeve tubular element having a central passage may include one air inlet extending in a tangential direction to the central passage. The sleeve tubular element having a central passage may include two air inlets extending in a tangential direction to the central passage. The sleeve tubular element having a central passage may include three air inlets extending in a tangential direction to the central passage. The sleeve tubular element having a central passage may include four air inlets extending in a tangential direction to the central passage.

[0048] At least one air inlet preferably enters the central passage at an inner diameter of the tubular element defining the inner diameter or perimeter of the central passage. At least two air inlets preferably enter the central passage at an inner diameter of the tubular element defining the inner diameter or perimeter of the central passage. At least three air inlets preferably enter the central passage at an inner diameter of the tubular element defining the inner diameter or perimeter of the central passage. At least four air inlets preferably enter the central passage at an inner diameter of the tubular element defining the inner diameter or perimeter of the central passage.

[0049] The two or more air inlets are preferably evenly spaced from the other inlets around the periphery of the central passageway.

[0050] At least one air inlet extending tangentially to the central passage enters the central passage adjacent an end surface defining the distal end of the sleeve. The expression "one air inlet extending tangentially to the central passage" may refer to any portion of the air inlet following the direction of an imaginary line that contacts but does not intersect an edge or boundary of the central passage at one point. The end surface forms a substantially closed end surface, allowing only the piercing element to extend therethrough. The end surface extends perpendicular to the longitudinal axis of the sleeve. The end surface prevents the inhaled air from flowing out through the distal end of the sleeve. The end surface directs the inhaled air towards the sleeve cavity.

[0051] At least one air inlet extending in a tangential direction to the central passage preferably enters the tubular element having the central passage at an end surface. Improved capsule depletion occurs when the tangential air inlet is located near the end surface of the central passage.

[0052] The tubular element may be a unitary, inseparable structure with the sleeve configured to hold the inhaler article within the housing cavity (i.e., integral with the sleeve). The tubular element may form a portion of a second, opposite end of the sleeve. The tubular element and the sleeve may be formed using an injection molding process. The tubular element and the sleeve may be formed simultaneously using an injection molding process.

[0053] The tubular element having a central passageway may extend or protrude into the sleeve cavity. The tubular element having a central passageway may have an outer surface having an outer diameter facing the inner surface of the sleeve. The inner surface of the sleeve defines the sleeve cavity.

[0054] The tubular element having a central passage may extend into the sleeve cavity a distance in the range of about 2 mm to about 10 mm, or about 3 mm to about 7 mm, or about 4 mm to about 6 mm, or about 5 mm. In these and other embodiments, the tubular element having a central passage may have an outer diameter in the range of about 4 mm to about 6.5 mm, or about 5 mm to about 6 mm, or about 5 mm to about 5.5 mm, or preferably about 5.25 mm. At least a portion of the tubular element having a central passage may be inserted into the received inhaler article. Preferably, at least 50% of the tubular element having a central passage may be inserted into the received inhaler article.

[0055] A tubular element having a central passage extending into the sleeve cavity may form an annular recess with the sleeve cavity configured to receive the distal end of an inhaler article. A tubular element having a central passage extending into the sleeve cavity may form an annular projection with the sleeve cavity configured to be received by the distal end of an inhaler article. A tubular element having a central passage extending into the sleeve cavity may form both an annular recess and an annular projection in the sleeve cavity configured to receive the distal end of an inhaler article.

[0056] The distal end of the inhaler article may be configured to mate with an annular recess formed by a tubular element having a central passage extending into the sleeve cavity. The distal end of the inhaler article may be configured to mate with an annular projection formed by a tubular element having a central passage extending into the sleeve cavity. The distal end of the inhaler article may be configured to mate with an annular recess and annular projection formed by a tubular element having a central passage extending into the sleeve cavity. The tubular element having a central passage may be configured to extend into the distal end of the inhaler article received within the sleeve cavity.

[0057] The annular protrusion formed by the tubular element having a central passage extending into the sleeve cavity may fit or slide into the received inhaler article distal end open tubular element. The annular protrusion formed by the tubular element having a central passage extending into the sleeve cavity may fit within the inhaler article distal end open tubular element. The annular protrusion formed by the tubular element having a central passage extending into the sleeve cavity may form an interference fit within the inhaler article distal end open tubular element. Thus, the central passage of the sleeve tubular element having a central passage may fit within the inhaler article distal end open tubular element having a central passage.

[0058] The holder for the inhaler article may include a piercing element configured to pierce or activate a capsule in the inhaler article. The piercing element may be secured to and extend from an inner surface of the housing. The piercing element may be configured to extend through an end surface of a second opposing surface of the sleeve and into the sleeve cavity along a longitudinal axis of the housing.

[0059] The piercing element may extend through an opening in the end surface of the sleeve. The piercing element may extend through the resealable element in the end surface of the sleeve. The resealable element may form an airtight seal or barrier at the end surface of the sleeve when the piercing element is not within the resealable element. The piercing element may extend through an opening in the end surface of the sleeve and substantially block air flow through the opening.

[0060] The piercing element may pass through the end surface and pierce the capsule within the capsule cavity. The resealable element, if present within the piercing opening, may be resealable after the piercing element is withdrawn or removed from the resealable element. The resealable element or membrane may include a septum or septum-like element. The resealable element or membrane may be formed of elastic materials such as rubber, silicone, metal foil co-laminated with a polymer, or latex and the like, or cellulose acetate tow, such as high density cellulose acetate tow.

[0061] The piercing element may be secured to the housing inner surface and may extend from the housing inner surface into the housing cavity along a longitudinal axis of the piercing element the length of the piercing element. The piercing element may be recessed a recessed distance from the open proximal end of the housing.

[0062] The distal or most upstream end of the inhaler article may contact a second, opposite end of the sleeve and urge the sleeve toward the piercing element. The sleeve may be coaxial with the piercing element. The sleeve may align the inhaler article to ensure that the piercing element activates the capsule within the inhaler article. The sleeve or holder may also mechanically retain and support the piercing element to prevent or reduce deflection of the piercing element.

[0063] The sleeve may define a first air inlet zone comprising at least one air opening through the sleeve. The first air inlet zone may include two or more, three or more, four or more, or about 1 to about 10 air openings, or about 3 to about 9 air openings. The first air inlet zone is proximate a first open end of the sleeve. The first air inlet zone is configured to allow air to flow into an airflow channel formed between the sleeve and the housing.

[0064] The sleeve may include a second air inlet zone downstream from the first air inlet zone. The second air inlet zone includes a second opposite end of the sleeve configured to allow air to enter the sleeve cavity. The second air inlet zone may include one, two or more, three or more, or four or more air openings, direct intakes, or intake air into the second opposite end of the sleeve at a tangent to the tubular element central passage to form a swirling intake airflow.

[0065] The holder may include a retaining ring element secured to the open proximal end of the housing. The retaining ring element retains the sleeve within the inhaler article cavity. The retaining ring has a thickness sufficient to stop movement or retain the sleeve within the inhaler article cavity of the holder.

[0066] The holder may include a spring element configured to bias the sleeve between a relaxed (or undeformed) state and a compressed (or deformed) state toward the open proximal end of the housing or away from the piercing element. The spring element may be contained within a housing cavity of the holder and may be compressed as the movable sleeve and inhaler article move toward the piercing element. The spring element may be located between the sleeve and the closed end of the housing and contacts the sleeve and the closed end of the housing. The spring element may be disposed around the piercing element. The spring element may be coaxial with the piercing element. The spring element may be a conical spring.

[0067] The spring element may be secured to the distal end or the closed end of the holder. The spring element may be secured to the second opposite end of the sleeve. The spring element may be secured to both the closed end of the holder and the second opposite end of the sleeve. The spring element may be a conical spring. A conical spring may advantageously provide a low-profile or slimmer design that may provide a more flexible design and a smaller overall compressed thickness. Providing a conical spring may also advantageously reduce the likelihood of the spring buckling when compressed compared to a cylindrical spring.

[0068] When the piercing element activates the inhaler article, the spring element biases the inhaler article away from and away from the piercing element. The spring element may be disposed around the piercing element. The spring element may be coaxial with the piercing element. The piercing element may extend beyond the spring element when the spring element is in a relaxed position. The piercing element may extend beyond the spring element when the spring element is in a compressed position. The piercing element may extend beyond the spring element when the spring element is in both the relaxed and compressed positions. The piercing element may extend beyond the spring element when the sleeve compresses the spring element.

[0069] The sleeve may include an elongated slot extending along a longitudinal length of the sleeve. When the sleeve includes an elongated slot, the housing may further include an alignment pin extending from an inner surface of the housing cavity. The alignment pin may be configured to mate with the elongated slot. Advantageously, the elongated slot and alignment pin provide a reliable path of movement between the relaxed and compressed positions.

[0070] The holder may include a marking element extending into the inhaler article cavity. The marking element may be configured to mark a surface of the inhaler article. The marking element may extend perpendicular to a longitudinal axis of the holder or the inhaler article. The marking element may be configured to mechanically mark the outer surface of the inhaler article. For example, the marking element may be configured to scratch, cut, scrape, score, fold or bend the outer surface of the inhaler article. The marking element may have a sharp edge configured to scratch the inhaler outer surface when received within the inhaler article cavity. The marking element may apply a color to the outer surface of the inhaler when received within the inhaler article cavity. The marking element may mark the inhaler outer surface when the piercing element penetrates a capsule disposed within the inhaler article, thus indicating that the inhaler article has been activated and may have been consumed by the user. This may also advantageously prevent a user from attempting to reuse an inhaler article that has already been previously activated.

[0071] The marking element may extend perpendicular to a longitudinal axis of the holder or inhaler article. The marking element may be formed from a rigid material configured to provide a visual indication that the marking element has contacted the outer surface of the inhaler. The marking element may be fixed to the holder housing. The marking element may form an alignment pin, as described above.

[0072] The marking element may extend through at least a portion of the thickness of the holder. The marking element may extend through the sleeve. The marking element may extend into the inhaler article cavity and into the sleeve. The marking element may extend at least a marking distance beyond the sleeve such that the marking element contacts the inhaler outer surface when the inhaler article is received within the inhaler article cavity. The marking element may be aligned with and mate with an elongated slot in the sleeve.

[0073] Recessing the penetrating element into the housing protects the penetrating element from contacting surfaces not intended to be received within the penetrating element. Recessing the penetrating element into the housing may also protect the penetrating element from being damaged or modified by surfaces not intended to be received within the penetrating element.

[0074] The piercing element may be recessed from the open proximal end by any suitable recessed distance. For example, the piercing element may be recessed from the open proximal end by a recessed distance of at least about 10%, at least about 20%, at least about 25%, or at least about 30%, or at least about 35%, or at least about 40% of the housing length. The piercing element may be recessed from the open proximal end by a recessed distance in the range of about 5% to about 50%, or about 10% to about 40%, or about 15% to about 40%, or about 20% to about 40% of the housing length.

[0075] The piercing element length may be any suitable length relative to the housing length. For example, the piercing element length may be about 25% to about 60%, or about 30% to about 50% of the housing length. The distal end of the piercing element may be fixed to a distal end adjacent to or at the distal end of the housing. The piercing element overall length may be coextensive within the housing length.

[0076] The housing inner surface has a diameter at an open proximal end and a diameter at a distal end. The diameter at the distal end may be smaller than the diameter at the open proximal end. The diameter of the housing inner surface may taper from the diameter at the open proximal end to the diameter at the distal end. The diameter of the housing inner surface may taper by any suitable amount. For example, the diameter of the housing inner surface may taper within a range of about 3% to about 13%, or about 5% to about 10% of the housing inner diameter at the proximal end.

[0077] The piercing element is formed of a rigid material. The rigid material is sufficiently rigid to pierce, puncture or activate a capsule contained within the inhaler article. The piercing element may be formed of a metal. The piercing element may be formed of a stainless steel, for example 316 stainless steel. The piercing element may be formed of a polymeric material. The piercing element may be formed of a fiber-reinforced polymeric material.

[0078] The housing may be formed of any rigid material. The housing may be formed of a polymeric material. Polymeric materials useful for forming the housing include polycarbonate, polypropylene, polyethylene, nylon, acrylonitrile butadiene styrene, styrene acrylonitrile, polyacrylate, polystyrene, PBT polyester, PET polyester, polyoxymethylene, polysulfone, polyethersulfone, polyethereetherketone, or liquid crystal polymer.

[0079] The inhaler article may be received in the holder such that the inhaler article outer surface and the holder housing outer surface are concentric. The longitudinal axis of the piercing element may be coaxial with the housing longitudinal axis and the inhaler longitudinal axis when the inhaler article is received in the holder. At least about 50% or at least about 75% of the housing length may be coextensive with the inhaler length when the inhaler article is received in the holder.

[0080] The holder may be formed by an insert molding technique. The penetrating element may be formed first, for example by molding, and then the housing may be molded around the penetrating element which couples to the penetrating element. The penetrating element may be a metal penetrating element, and the housing may be molded around the metal penetrating element to secure the metal penetrating element to the housing. The metal penetrating element may include a protrusion or recess at the distal end of the penetrating element to increase the surface area of ​​the distal end of the penetrating element and to improve fixation within the housing molding material.

[0081] The inhaler article associated with the above-mentioned holder is configured to receive a swirling inhalation airflow directly into the distal end of the inhaler article. The swirling inhalation airflow continues downstream into the capsule cavity and induces rotation of the capsule received (or located) in the capsule cavity. The activated capsule releases a dose of particles into the downstream swirling inhalation airflow through the mouthpiece to the consumer. The distal or most upstream end of the inhaler article includes an open tubular element that defines an open central passage. Thus, a swirling inhalation airflow is generated upstream from the inhaler article, and the swirling inhalation airflow enters the distal or most upstream end of the inhaler article and is directed into the capsule cavity to rotate or spin the capsule located in the capsule cavity.

[0082] The inhaler article comprises a body extending along a longitudinal axis of the inhaler from a mouthpiece end to a distal end. A capsule cavity is defined within the body bounded downstream by a filter element and upstream by an open tubular element defining a central passage. The central passage forms an open air inlet opening extending from the distal end of the body to the capsule cavity. A capsule is disposed within the capsule cavity, the central passage having a smaller diameter than the capsule.

[0083] The inhaler body may resemble a smoking article or a cigarette in size and shape. The inhaler body may have an elongated body extending along the longitudinal axis of the inhaler article. The inhaler body may have a substantially uniform outer diameter along the length of the elongated body. The inhaler body may have a circular cross-section that may be uniform along the length of the elongated body. The inhaler body may have an outer diameter in the range of about 6 mm to about 10 mm, or about 7 mm to about 10 mm, or about 7 mm to about 9 mm, or about 7 mm to about 8 mm, or about 7.2 mm. The inhaler body may have a length (along the longitudinal axis) in the range of about 40 mm to about 80 mm, or about 40 mm to about 70 mm, or about 40 mm to about 50 mm, or a length of 45 mm.

[0084] The inhaler article has an open distal or upstream-most end defined by an open tubular element that defines an open central passageway. The open central passageway defines a cylindrical open opening extending from the capsule cavity to the open distal or upstream-most end of the inhaler article. The open tubular element that defines the open central passageway may have a length in the range of about 3 mm to about 12 mm, or about 3 mm to about 7 mm, or about 4 mm to about 6 mm, or about 5 mm.

[0085] The central passage may have a uniform inner or open diameter extending from the capsule cavity to the open distal or most upstream end of the inhaler article. The central passage may have an inner diameter that is at least about 50%, or at least about 70%, or at least about 75% of the diameter of the body distal end. The central passage may have a uniform inner or open diameter in the range of about 3 mm to about 6.5 mm, or about 4 mm to about 6 mm, or about 5 mm to about 6 mm, or about 5.5 mm.

[0086] The open tubular element defining the open central passage may be formed from a cellulose material. The open tubular element defining the open central passage may be formed from a cellulose acetate material. The open tubular element is preferably formed from a biodegradable material. The open tubular element defining the open central passage may have a thickness in the range of about 0.5 mm to about 1.5 mm, or about 0.5 mm to about 1 mm.

[0087] The filter element, located downstream of the capsule cavity, may extend from the capsule cavity to the mouthpiece end of the inhaler article. The filter element may have a length in the range of about 10 mm to about 30 mm, preferably about 15 mm to about 25 mm, and more preferably about 20 mm to about 22 mm.

[0088] The capsule cavity may be defined by an open tubular element of the inhaler article. The open tubular element may be joined between and aligned in abutment with the tubular element forming the distal end of the inhaler article and the filter element. These elements may be joined using a wrapper. The open tubular element defining the capsule cavity may be formed of a biodegradable material such as cardboard or cardboard.

[0089] The capsule cavity may have an inner diameter within the range of about 6 mm to about 7 mm, or about 6.5 mm to about 6.7 mm. The capsule cavity may have a lateral length within the range of about 15 mm to about 30 mm, or about 20 mm to about 25 mm.

[0090] The capsule cavity may be defined by an open tubular element of the inhaler article. The open tubular element may be joined between and aligned in abutment with the tubular element forming the distal end of the inhaler article and the filter element. These elements may be joined using a wrapper. The open tubular element defining the capsule cavity may be formed of a biodegradable material such as cardboard or cardboard.

[0091] The capsule cavity may have an inner diameter within the range of about 6 mm to about 7 mm, or about 6.5 mm to about 6.7 mm. The capsule cavity may have a lateral length within the range of about 15 mm to about 30 mm, or about 20 mm to about 25 mm.

[0092] The capsule cavity may define a cylindrical space configured to contain the capsule (e.g., the capsule may have an oval or circular cross-section). The capsule cavity may have a substantially uniform or uniform diameter along the length of the capsule cavity. The capsule cavity may have a fixed cavity length. The capsule cavity has a cavity inner diameter perpendicular to the longitudinal axis, and the capsule has a capsule outer diameter. The capsule cavity may be sized to contain an oval capsule. The capsule cavity may have a substantially cylindrical or cylindrical cross-section along the capsule cavity length. The capsule cavity may have a uniform inner diameter. The capsule may have an outer diameter that is about 80% to about 95% of the inner diameter of the capsule cavity. The configuration of the capsule cavity relative to the capsule may facilitate limited movement of the capsule during activation or penetration of the capsule.

[0093] The capsule cavity may be defined by an open tubular element. The open tubular element may be joined between and aligned in abutment with the open tubular element forming the distal end of the inhaler article and the filter element. These elements may be joined using a wrapper. The open tubular element defining the capsule cavity may be formed of a biodegradable material such as cardboard or cardboard.

[0094] The configuration of the capsule cavity relative to the capsule may encourage the capsule to rotate stably within the capsule cavity. The longitudinal axis of the capsule may rotate stably coaxially with the longitudinal axis of the inhaler body during inhalation. The configuration of the capsule cavity relative to the capsule may encourage the capsule to rotate with some vibration within the capsule cavity.

[0095] Stable rotation refers to the longitudinal axis of the inhaler body being substantially parallel or coaxial with the axis of rotation of the capsule. Stable rotation may refer to the lack of forward movement of the rotating capsule. The longitudinal axis of the inhaler body is preferably substantially coextensive with the axis of rotation of the capsule. Stable rotation of the capsule may provide uniform entrainment of a portion of the nicotine particles from the capsule over two or more, or five or more, or ten or more "puffs" or inhalations by the consumer.

[0096] The capsule may be sealed within the inhaler article prior to consumption. The inhaler article may be contained within a sealed or airtight container or bag. The inhaler article may include one or more peelable or removable sealing layers for covering one or more air inlet channels, or air outlets, or mouthpiece of the inhaler article.

[0097] The capsule may rotate about its longitudinal or central axis as air flows through the inhaler article. The capsule may be formed of an airtight material that may be pierced or perforated by a piercing element that may be separate from the inhaler or may be associated with the inhaler. The capsule may be formed of a metallic or polymeric material that functions to keep contaminants out of the capsule but may be pierced or perforated by a piercing element prior to consumption of the nicotine particles therein. The capsule may be formed of a polymeric material. The polymeric material may be hydroxypropyl methylcellulose (HPMC). The capsule may be a size 1 to size 4 capsule, or a size 3 capsule.

[0098] As described herein, the separate holder forms a single opening through the capsule received within the capsule cavity.

[0099] The capsule contains medicamentally active particles. The medicamentally active particles may include nicotine (also referred to as "nicotine powder" or "nicotine particles"), and optionally flavor-containing particles (also referred to as "flavor particles"). The capsule may contain a predetermined amount of nicotine particles and optionally flavor particles. The capsule may contain sufficient nicotine particles to provide at least 2 inhalations or "puffs", or at least about 5 inhalations or "puffs", or at least about 10 inhalations or "puffs". The capsule may contain sufficient nicotine particles to provide about 5-50 inhalations or "puffs", or about 10-30 inhalations or "puffs". Each inhalation or "puff" may deliver about 0.1 mg to about 3 mg of nicotine particles to the user's lungs, or about 0.2 mg to about 2 mg of nicotine particles to the user's lungs, or about 1 mg of nicotine particles to the user's lungs.

[0100] The nicotine particles may have any useful concentration of nicotine based on the particular formulation employed. The nicotine particles may have at least about 1% up to about 30% nicotine by weight, or about 2% to about 25% nicotine by weight, or about 3% to about 20% nicotine by weight, or about 4% to about 15% nicotine by weight, or about 5% to about 13% nicotine by weight. Preferably, with each inhalation or "puff", about 50 to about 150 micrograms of nicotine may be delivered to the user's lungs.

[0101] The capsule may hold or contain at least about 5 mg of nicotine particles, or at least about 10 mg of nicotine particles. The capsule may hold or contain less than about 900 mg of nicotine particles, or less than about 300 mg of nicotine particles, or less than 150 mg of nicotine particles. The capsule may hold or contain between about 5 mg and about 300 mg of nicotine particles, or between about 10 mg and about 200 mg of nicotine particles.

[0102] When flavor particles are blended or combined with the nicotine particles in the capsule, the flavor particles may be present in an amount that provides the desired flavor with each inhalation or "puff" delivered to the user.

[0103] The nicotine particles may have any size distribution useful for preferential inhalation delivery into the lungs of the user. The capsule may contain particles other than nicotine particles. The nicotine particles and other particles may form a powder system.

[0104] The capsule may hold or contain at least about 5 mg of dry powder (also referred to as a powder system), or at least about 10 mg of dry powder. The capsule may hold or contain less than about 900 mg of dry powder, or less than about 300 mg of dry powder, or less than about 150 mg of dry powder. The capsule may hold or contain from about 5 mg to about 300 mg of dry powder, or from about 10 mg to about 200 mg of dry powder, or from about 25 mg to about 100 mg of dry powder.

[0105] The dry powder or powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system consisting of nicotine particles with a particle size of about 5 micrometers or less, or in the range of about 1 micrometer to about 5 micrometers.

[0106] The nicotine-containing particles may have a mass median aerodynamic diameter of about 5 micrometers or less, or in the range of about 0.5 micrometers to about 4 micrometers, or in the range of about 1 micrometer to about 3 micrometers, or in the range of about 1.5 micrometers to about 2.5 micrometers. The mass median aerodynamic diameter is preferably measured with a cascade impactor.

[0107] The flavor-containing particles may have a mass median aerodynamic diameter of about 20 micrometers or more, or about 50 micrometers or more, or in the range of about 50 to about 200 micrometers, or in the range of about 50 to about 150 micrometers. The mass median aerodynamic diameter is preferably measured with a cascade impactor.

[0108] The dry powder may have an average particle size of about 60 micrometers or less, or in the range of about 1 micrometer to about 40 micrometers, or in the range of about 1.5 micrometers to about 25 micrometers, where average particle size refers to the average particle size per mass, and is preferably measured by laser diffraction, laser diffusion, or electron microscopy.

[0109] The nicotine in the powder system or in the nicotine particles may be nicotine free base, or nicotine salt or nicotine salt hydrate that is pharma- ceutical acceptable.Useful nicotine salt or nicotine salt hydrate includes, for example, nicotine pyruvate, nicotine citrate, nicotine aspartate, nicotine lactate, nicotine bitartrate, nicotine salicylate, nicotine fumarate, nicotine mono-pyruvate, nicotine glutamate, or nicotine hydrochloride.The compound that combines with nicotine to form a salt or salt hydrate may be selected based on its expected pharmacological effect.

[0110] Preferably, the nicotine particles include an amino acid. Preferably, the amino acid may be leucine, such as L-leucine. Providing nicotine-containing particles with an amino acid, such as L-leucine, may reduce the adhesive force of the nicotine-containing particles and may also reduce the attractive force between nicotine particles, thus reducing the aggregation of the nicotine particles. Similarly, it may also reduce the adhesive force to flavor-containing particles, thus reducing the aggregation of nicotine particles with flavor particles. Therefore, the powder system described herein may be a free-flowing material and may have a stable relative particle size of each powder component, even when nicotine particles and flavor particles are combined.

[0111] Preferably, the nicotine may be a surface-modified nicotine salt, in which case the nicotine salt particles include coated or composite particles. A preferred coating or composite material may be L-leucine. One particularly useful nicotine particle may be nicotine bitartrate with L-leucine.

[0112] The powder system may comprise a population of flavour particles, which may have any useful size distribution, optionally for inhalation delivery into the mouth or oral cavity of a user.

[0113] The powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system flavor particle population consisting of particles having a particle size of about 20 micrometers or more. The powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system flavor particle population consisting of particles having a particle size of about 50 micrometers or more. The powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system flavor particle population consisting of particles having a particle size in the range of about 50 micrometers to about 150 micrometers.

[0114] The flavor-containing particles may include a compound to reduce adhesion or surface energy and the resulting agglomeration. The flavor particles may be surface-modified with an adhesion-reducing compound to form coated flavor particles. One preferred adhesion-reducing compound may be magnesium stearate. Providing flavor particles, particularly coating the flavor particles, with an adhesion-reducing compound such as magnesium stearate may reduce the adhesion of the flavor-containing particles and may also reduce the attractive forces between the flavor particles and therefore reduce the agglomeration of the flavor particles. Therefore, the agglomeration of the flavor particles with the nicotine particles may also be reduced. Therefore, the powder system described herein may have a stable relative particle size of the nicotine-containing particles and the flavor-containing particles even when the nicotine particles and the flavor particles are combined. Preferably, the powder system may be free-flowing.

[0115] Conventional formulations for dry powder inhalation contain carrier particles that function to increase the fluidization of active particles, because active particles may be too small to be affected by simple airflow through the inhaler.Powder systems may include carrier particles.These carrier particles may be saccharides, such as lactose or mannitol, that may have a particle size of more than about 50 micrometers.Carrier particles may be utilized in formulations to improve dose uniformity by acting as diluents or bulking agents.

[0116] Powder systems utilized with the nicotine powder delivery systems described herein may be carrier-free or substantially free of saccharides such as lactose or mannitol. The absence of carriers or the substantial absence of saccharides such as lactose or mannitol may allow the nicotine to be inhaled and delivered to the user's lungs at an inhalation volume or airflow similar to that of a typical smoking method.

[0117] Nicotine particles and flavors may be combined in a single capsule.As mentioned above, nicotine particles and flavors may each have a reduced adhesive force, which results in a stable particle formulation when the particle size of each component does not change substantially when combined.Alternatively, the powder system includes nicotine particles contained in a single capsule and flavor particles contained in a second capsule.

[0118] The nicotine particles and flavor particles may be combined in any useful relative amounts such that the user notices the flavor particles when consumed together with the nicotine particles. Preferably, the nicotine particles and flavor particles form at least about 90% by weight, or at least about 95% by weight, or at least about 99% by weight, or 100% by weight of the total weight of the powder system.

[0119] The inhaler and inhaler system are less complicated and have a simplified airflow path compared to conventional dry powder inhalers. Advantageously, the rotation of the capsule in the inhaler body may aerosolize the nicotine particles or powder system and help maintain a free-flowing powder. Therefore, the inhaler article may not require the high inhalation volume typically utilized by conventional inhalers to deliver the above-mentioned nicotine particles deep into the lungs.

[0120] The inhaler article may use a flow rate of less than about 5 L / min, or less than about 3 L / min, or less than about 2 L / min, or less than about 1.6 L / min. Preferably, the flow rate may be in the range of about 1 L / min to about 3 L / min, or about 1.5 L / min to about 2.5 L / min. Preferably, the inhalation volume or flow rate may be similar to that of the Health Canada smoking method, i.e., about 1.6 L / min.

[0121] The inhaler system may be used by the consumer as in smoking a conventional cigarette or vaping an electronic cigarette. Such smoking or vaping may be characterized by two steps, during a first step, a small volume containing the total amount of nicotine desired by the consumer is drawn into the oral cavity, followed by a second step, during which this small volume containing an aerosol containing the desired amount of nicotine is further diluted by fresh air and drawn deeper into the lungs. Both steps are controlled by the consumer. During the first inhalation step, the consumer may decide the amount of nicotine to be inhaled. During the second step, the consumer may decide the amount to be diluted from the first amount and drawn deeper into the lungs to maximize the concentration of the active agent delivered to the epithelial surface of the airways. This smoking mechanism may be called "puff-inhale-exhale".

[0122] All scientific and technical terms used herein have the meanings commonly used in the art unless otherwise specified. The definitions provided herein are provided to facilitate understanding of certain terms used frequently herein.

[0123] As used herein, the singular forms "a," "an," and "the" include embodiments having plural referents unless the content clearly dictates otherwise.

[0124] As used herein, "or" is generally employed in its inclusive sense unless the context clearly dictates otherwise. The term "and / or" refers to one or all of the listed elements or a combination of any two or more of the listed elements.

[0125] As used herein, the words "have," "having," "include," "including," "comprise," "comprising," and the like are used in an open-ended sense and generally mean "including, but not limited to." It should be understood that "consisting essentially of," "consisting of," and the like are encompassed by "comprising" and the like.

[0126] The words "preferred" and "preferably" refer to embodiments of the invention that may offer certain advantages, under particular circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Moreover, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the present disclosure, including the claims.

[0127] The invention will now be further described with reference to the figures. [Brief description of the drawings]

[0128] [Figure 1] FIG. 1 is a perspective view of an exemplary inhaler system. [Diagram 2] FIG. 2 is a cross-sectional schematic diagram of the exemplary inhaler system of FIG. [Diagram 3] FIG. 3 is a cross-sectional schematic diagram of an exemplary inhaler article. [Figure 4] FIG. 4 is a cross-sectional schematic diagram of an exemplary inhaler article received within the sleeve depicted in FIG. [Diagram 5] FIG. 5 is a cross-sectional schematic view of an exemplary sleeve. [Figure 6] FIG. 6 is a cross-sectional schematic view of another exemplary sleeve. [Figure 7]FIG. 7 is a cross-sectional schematic diagram of an exemplary vortex tunnel with one to four tangential air inlets. [Figure 8] FIG. 8 is a cross-sectional schematic diagram of an exemplary vortex tunnel with one to four tangential air inlets. [Figure 9] FIG. 9 is a cross-sectional schematic diagram of an exemplary vortex tunnel with one to four tangential air inlets. [Figure 10] FIG. 10 is a cross-sectional schematic diagram of an exemplary vortex tunnel with one to four tangential air inlets. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0129] The schematic diagrams are not necessarily to scale and are presented for purposes of illustration, not limitation. The drawings illustrate one or more aspects described in the present disclosure. However, it will be understood that other aspects not shown in the drawings are within the scope and spirit of the present disclosure.

[0130] Figure 1 is a perspective view of an exemplary inhaler system 100. Figure 2 is a cross-sectional schematic view of the exemplary inhaler system 100 of Figure 1. Figure 3 is a cross-sectional schematic view of an exemplary inhaler article 150. Figure 4 is a cross-sectional schematic view of an exemplary inhaler article 150 received within the sleeve 120 illustrated in Figure 2.

[0131] The inhaler system 100 includes an inhaler article 150 and a separate holder 110. The inhaler article 150 may be received within the holder 110 for actuating or piercing a capsule 160 disposed within the inhaler article 150. The inhaler article 150 remains within the holder 110 during use by a consumer. The holder 110 is configured to create or induce a swirling inhalation airflow that enters the received inhaler article 150.

[0132] The inhaler system 100 includes an inhaler article 150 and a holder 110. The inhaler article 150 has an inhaler longitudinal axis L extending from a mouthpiece end 154 to a distal end 156. Aand a capsule 160 disposed within the inhaler article body 151. The holder 110 includes a movable sleeve 120 that holds the inhaler article 150 received within a sleeve cavity 122.

[0133] The holder 110 for the inhaler article 150 includes a housing 111 with a housing cavity 112 for receiving the inhaler article 150, and a sleeve 120 configured to hold the inhaler article 150 within the housing cavity 112. The sleeve 120 defines a sleeve cavity 122 and is aligned along a longitudinal axis L of the housing 111. A The sleeve 120 is movable within the housing cavity 112 along a first open end 124 and a second opposite end 126. The second opposite end 126 of the sleeve 120 is configured to allow air to enter the sleeve cavity 122. The second opposite end 126 of the sleeve 120 is configured to create or induce a swirl in the air entering the sleeve cavity 122.

[0134] The holder 110 may include a piercing element 101 secured to and extending from the housing inner surface 109. The piercing element 101 may be configured to extend through a second opposite end 126 of the sleeve 120 and into a sleeve cavity 122 along a longitudinal axis of the housing 111. The holder 110 may include a spring element 102 configured to bias the sleeve 120 away from the piercing element 101.

[0135] The sleeve 120 may include an elongated slot 128 (see FIG. 5 ) extending along the longitudinal length of the sleeve 120. The housing 111 may further include a pin 127 extending from the inner surface 109 of the housing cavity 112. The pin 127 may be configured to mate with the elongated slot 128.

[0136] The inhaler article 150 has an inhaler longitudinal axis L extending from the mouthpiece end 154 to the distal end 156. AThe capsule cavity 155 includes a body 151 extending along a distal end 156 of the body. A capsule cavity 155 is disposed within the body 151 and is bounded downstream by a filter element 157 and upstream by an open tubular element 153 which defines a central passage 152. The central passage 152 forms an open air inlet opening which extends from a distal end 156 of the body to the capsule cavity 155. A capsule 160 is disposed within the capsule cavity 155. The central passage 152 has a smaller diameter than the capsule 160.

[0137] As illustrated with reference to FIGS. 4 and 5, the central passageway 152 of the open-ended tubular element 153 of the inhaler article 150 aligns and mates with the central passageway 132 of the sleeve tubular element 130 .

[0138] The inhalation air inlet 138 enters the sleeve tubular element 130 at a tangent to the sleeve tubular element 130 and creates a swirling inhalation airflow into the central passage 152 of the open tubular element 153 of the received inhaler article 150. The swirling inhalation airflow flows along the central passage 152 of the open tubular element 153 of the received inhaler article 150 downstream with respect to the capsule cavity to induce rotation of the capsule and to release particles into the inhalation airflow.

[0139] The sleeve 120 defines a first air inlet zone 170 comprising at least one air opening 129 through the sleeve 120. The first air inlet zone 170 is proximate the first open end 124 of the sleeve 120. The first air inlet zone 170 is configured to allow air to flow into an airflow channel formed between the sleeve 120 and the housing 111. The sleeve comprises a second air inlet zone 180 downstream from the first air inlet zone 170. The second air inlet zone 180 comprises a second opposite end 126 of the sleeve 120 and is configured to allow air to enter the sleeve cavity 122. The second air inlet zone 180 comprises at least one air opening or air inlet 138 through the sleeve 120 and into the sleeve tubular element 130 having a central passageway 132.

[0140] 6 is a cross-sectional schematic diagram of another exemplary sleeve 120. A second, opposite end 126 of the sleeve 120 includes a sleeve tubular element 130 defining a central passage 132, an end surface 136, and an open end 134. The central passage 132 is in fluid communication with the sleeve cavity 122. The open end 132 of the sleeve tubular element 130 may extend into the sleeve cavity 122. The sleeve tubular element 130 includes at least one air inlet 138 that allows air to enter the central passage 132. The at least one air inlet 138 extends in a direction that is tangential to the central passage 132.

[0141] The distal end 156 of the inhaler article 150 may slide onto the sleeve tubular element 130. The inhalation air inlet 138 enters the sleeve tubular element 130 tangent to the central passage 132 and forms a swirling inhalation airflow into the central passage 152 of the open tubular element 153 of the received inhaler article 150. The swirling inhalation airflow flows along the central passage 152 of the open tubular element 153 of the received inhaler article 150 downstream with respect to the capsule cavity to induce rotation of the capsule and to release particles into the inhalation airflow.

[0142] The sleeve tubular element 130 may extend into the sleeve cavity 122, forming an annular recess 131 with the sleeve cavity 122 configured to receive the distal end 156 of the inhaler article 150. The protrusion formed by the sleeve tubular element 130 slides into the open tubular element 153 of the inhaler article 150. The sleeve tubular element 130 is now configured to extend into the distal end 156 of the inhaler article 150 received within the sleeve cavity 122.

[0143] The sleeve tubular element 130 may extend about 5 mm into the sleeve cavity 122 and may have an outer diameter of about 5.5 mm and an inner diameter of about 4 mm. The central passage 152 of the open tubular element 153 of the received inhaler article 150 may have an inner diameter of about 5.5 mm to provide an interference fit between the sleeve tubular element 130 and the annular recess 131.

[0144] 7-10 are cross-sectional schematic diagrams of exemplary sleeve tubular elements 130 having a central passage 132 with one to four tangential air inlets 138. The inner diameter of the sleeve tubular element 130 may be about 4 mm. FIG. 7 illustrates a single tangential air inlet 138 having a diameter of about 1.45 mm. FIG. 8 illustrates two tangential air inlets 138, each having a diameter of about 1 mm that enter the sleeve tubular element 130 at 180 degrees from each other. FIG. 9 illustrates three tangential air inlets 138, each having a diameter of about 0.85 mm that enter the sleeve tubular element 130 at 120 degrees from each other. FIG. 10 illustrates four tangential air inlets 138, each having a diameter of about 0.6 mm that enter the sleeve tubular element 130 at 90 degrees from each other.

Claims

1. 1. A holder for an inhaler article, comprising: a housing having a housing cavity for receiving an inhaler article; a sleeve configured to hold an inhaler article within the housing cavity and movable within the housing cavity along a longitudinal axis of the housing, the sleeve comprising: A sleeve cavity; a first open end and a second opposite end, the first open end configured to receive an inhaler article; the second opposite end of the sleeve a tubular element having a central passage extending into and in fluid communication with said sleeve cavity, the tubular element having an outer surface having an outer diameter facing an inner surface of the sleeve, forming an annular recess with the sleeve cavity configured to receive a distal end of an inhaler article; and a sleeve having at least one air inlet. The holder, wherein the at least one air inlet extends in a direction tangential to the central passage to allow air to enter the sleeve cavity and to induce a swirling airflow pattern in the air entering the sleeve cavity.

2. 2. The holder of claim 1, wherein the tubular element includes at least two air intakes extending in a direction tangential to the central passage to allow air to enter the sleeve cavity and to induce a swirling airflow pattern in the air entering the sleeve cavity.

3. The holder of any of claims 1 to 2, wherein the annular recess is configured to hold a distal end of an inhaler article.

4. A holder according to any preceding claim, wherein the tubular element is coaxial with the longitudinal axis of the housing.

5. The holder of any of claims 1 to 4, wherein the tubular element is configured to extend into a distal end of an inhaler article received within the sleeve cavity.

6. 6. The holder of claim 1, further comprising a penetrating element secured to and extending from an inner surface of the housing, the penetrating element configured to extend through the second opposite end of the sleeve and into the sleeve cavity along the longitudinal axis of the housing.

7. The holder of claim 6 , further comprising a spring element configured to bias the sleeve away from the piercing element.

8. A holder as claimed in any preceding claim, wherein substantially all of the intake air enters the tubular element in a direction that is tangential to the central passage.

9. A holder for an inhaler article as described in any one of claims 1 to 8, wherein the sleeve has an elongated slot extending along the longitudinal length of the sleeve, and the housing further has a pin extending from an inner surface of the housing cavity, the pin being configured to mate with the elongated slot.

10. 10. The holder of claim 1, wherein the sleeve defines a first air inlet zone having at least one air opening therethrough, the first air inlet zone adjacent the first open end of the sleeve, the first air inlet zone configured to allow air to flow into an airflow channel formed between the sleeve and the housing, and the sleeve comprises a second air inlet zone downstream from the first air inlet zone, the second air inlet zone comprising the second opposite end of the sleeve configured to allow air to enter the sleeve cavity.

11. 1. An inhaler system comprising: an inhaler article comprising a body extending along an inhaler longitudinal axis from a mouthpiece end to a distal end, and a capsule disposed within the inhaler article body; An inhaler system comprising: a holder for an inhaler article according to any one of claims 1 to 10, wherein the sleeve holds the inhaler article received within the sleeve cavity.

12. 12. The inhaler system of claim 11, wherein the capsule is held within a capsule cavity and configured to receive a swirling inhalation airflow formed by the second opposite end of the sleeve, the capsule cavity being bounded downstream by a filter element and upstream by an open tubular element.

13. 13. The inhaler system of claim 12, wherein an open tubular element of the inhaler article mates with the second opposite end of the sleeve tubular element.

14. The inhaler system of any one of claims 11 to 13, wherein the mouthpiece end of the inhaler article forms the mouthpiece of the inhaler system.

Citation Information

Patent Citations

  • Inhaler with spiral end plug

    JP2019536454A

  • Heat diffuser for aerosol generating device

    WO2019064119A1

  • Inhaler with vortex tunnel

    WO2019130158A1

  • Inhaler with vortex capsule cavity

    WO2019186372A1

Cited By

  • Inhaler article holder for high dose delivery

    JP2024513649A